Additionally, as an important marker for migration, high expression of VIM in GBM was also validated by Western blot and IHC in patient samples, and the result was consistent with our transcriptomic data (Figure 2C), suggesting that VIM could be used as a biopsy marker for GBM diagnosis. The gene discussed is VIM; the disease is glioblastoma.